How to taper off vilazodone (Vilazodone) and initiate bupropion (Wellbutrin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tapering off vilazodone and starting Wellbutrin should be done under medical supervision, with a gradual reduction of vilazodone over 2-4 weeks while introducing Wellbutrin at a low dose and gradually increasing it. When switching from one antidepressant to another, it's crucial to consider the potential for discontinuation symptoms and the time it takes for the new medication to become effective. According to the American College of Physicians guideline 1, when choosing pharmacologic therapy to treat patients with acute major depression, second-generation antidepressants should be selected based on adverse effect profiles, cost, and patient preferences.

Key considerations for tapering vilazodone include:

  • Gradually reducing the dose over 2-4 weeks to minimize discontinuation symptoms such as dizziness, headache, nausea, and mood changes
  • Starting Wellbutrin at a low dose, typically 150mg once daily, and increasing it as tolerated to the target dose
  • Monitoring patient status, therapeutic response, and adverse effects of antidepressant therapy on a regular basis, beginning within 1 to 2 weeks of initiation of therapy, as recommended by the American College of Physicians 1

The rationale behind this approach is to allow the brain to adapt to the changes in neurochemicals, as vilazodone affects serotonin levels, while Wellbutrin primarily affects dopamine and norepinephrine. It's essential to stay hydrated, maintain regular sleep patterns, and report any concerning side effects to the doctor during this transition. By following this gradual tapering and introduction method, patients can minimize potential side effects and increase the likelihood of a successful transition from vilazodone to Wellbutrin.

From the FDA Drug Label

2.5 Discontinuing Treatment with Vilazodone Hydrochloride Adverse reactions may occur upon discontinuation of vilazodone hydrochloride [see Warnings and Precautions (5. 5)]. A gradual reduction in dosage rather than abrupt cessation is recommended whenever possible. Vilazodone hydrochloride should be down tapered from the 40 mg once daily dose to 20 mg once daily for 4 days, followed by 10 mg once daily for 3 days. Patients taking vilazodone hydrochloride 20 mg once daily should be tapered to 10 mg once daily for 7 days.

To taper off vilazodone and start Wellbutrin, gradually reduce the vilazodone dosage as follows:

  • If taking 40 mg once daily, taper to 20 mg once daily for 4 days, then to 10 mg once daily for 3 days.
  • If taking 20 mg once daily, taper to 10 mg once daily for 7 days. After tapering off vilazodone, Wellbutrin can be initiated. However, the exact timing of initiation is not specified in the vilazodone label 2. Key considerations:
  • Tapering vilazodone gradually is recommended to minimize adverse reactions.
  • The vilazodone label does not provide specific guidance on initiating Wellbutrin after tapering off vilazodone.

From the Research

Tapering Off Vilazodone

  • To taper off vilazodone, a gradual reduction in dose over time is recommended, as sudden discontinuation can lead to withdrawal symptoms 3.
  • The most promising strategy for psychiatric drug discontinuation, including vilazodone, appears to be hyperbolic tapering by exponential dose reduction 3.
  • However, there is a lack of standardization among guidelines, making it difficult for prescribers to determine the best approach for tapering off vilazodone 3, 4.

Starting Wellbutrin (Bupropion)

  • Bupropion, also known as Wellbutrin, can be used to manage withdrawal symptoms, as seen in a case study where a patient with stimulant use disorder and unspecified bipolar disorder experienced significant improvement in psychotic and mood symptoms after starting bupropion 5.
  • Bupropion has been shown to be effective in managing opioid withdrawal, with fewer adverse effects compared to other medications such as clonidine or lofexidine 6.
  • When starting bupropion, it is essential to consider the patient's medical history, current medications, and potential interactions, as bupropion can interact with other drugs, including selective serotonin reuptake inhibitors (SSRIs) like vilazodone 7.

Combination of Tapering Off Vilazodone and Starting Wellbutrin

  • There is limited research on the specific combination of tapering off vilazodone and starting Wellbutrin, and more studies are needed to provide guidance on this topic 4.
  • However, based on the available evidence, a gradual tapering off vilazodone using a hyperbolic tapering strategy, followed by the introduction of Wellbutrin, may be a viable approach, but this should be done under the guidance of a healthcare professional 3, 5.

Related Questions

What are the symptoms of Selective Serotonin Reuptake Inhibitor (SSRI) withdrawal?
What is the recommended tapering schedule when switching from Effexor (venlafaxine) to Cymbalta (duloxetine)?
How to taper 60mg of Cymbalta (duloxetine) while starting Lamictal (lamotrigine)?
What is the recommended approach for managing withdrawal from Ritalin (methylphenidate)?
What medication class is considered first-line treatment for Major Depressive Disorder (MDD)?
Should a patient with a history of myocardial infarction (MI) on Aspirin (ASA) 81mg and Crestor (Rosuvastatin) 20mg with an elevated Low-Density Lipoprotein (LDL) level of Hyperlipidemia be treated to further lower their LDL?
What is the diagnosis for a 55-year-old female patient who presented with sudden onset of stiffening of both hands, severe headache, and loss of consciousness after a phone argument, with initial Glasgow Coma Scale (GCS) of 3, improving to 15, and abnormal motor strength in lower extremities, following a computed tomography (CT) scan showing no bleeding or infarct, but possible subarachnoid hemorrhage (SAH)?
What is a suitable alternative to Sertraline (selective serotonin reuptake inhibitor) and Vilazodone (partial serotonin receptor agonist) for a patient with intolerance and inadequate response?
Are there any intravenous (IV) medications like Lokelma (sodium zirconium cyclosilicate)?
What naturally regulates blood glucose and lipid profiles?
Is there a correlation between HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors, commonly referred to as statins, and the development of dementia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.